Researchers have identified a promising triple drug therapy that may block resistance in pancreatic cancer, one of the deadliest forms of the disease. The approach targets multiple pathways cancer cells use to evade treatment, potentially improving patient outcomes. Experts say the findings could open the door to more effective combination therapies in future cancer care. https://republicnews.us/article/triple-drug-therapy-blocks-pancreatic-cancer-resistance